Exenatide for Smoking Cessation and Prevention of Weight Gain

NCT05610800 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Smoking Cessation
Weight Gain

Interventions

DRUG: Exenatide 2 milligram (mg) Injection
DRUG: Placebo
DRUG: Nicotine patch
BEHAVIORAL: Smoking Cessation Counseling

Sponsor

The University of Texas Health Science Center, Houston